Tetanus Toxoid

8 Drugs classified under this active ingredient

Tetanus Toxoid 5 Lf, Diphtheria Toxoid 2 Lf, Pertussis Toxoid 2.5 mcg, Filamentous Haemagglutinin 5 mcg, Pertactin 3 mcg, Fimbriae Types 2+3 5 mcg.
Cont. in 0.5 ml :
Diphtheria Toxoid 2 Lf ;Tetanus Toxoid 5 Lf ;
Pertussis Toxoid 2.5 microg; Filamentous Haemagglutinin 5 microg;
Pertactin 3 microg; Fimbriae Types 2 and 3 5 microg;
Aluminium (aluminium phosphate by calc.) 0.33 mg (1.5mg)
VIAL: 1/5/10 x 0.5 ml. susp for I.M.  inj. into deltoid musc.
 Immun. schedule as per health auth. recommen. Re-dosing at 5-10 years  interval. See lit.
 Active booster immun. for the prevent. of tetanus, diphtheria and pertussis in childr, adolesc. and adlts aged 4 to 64 years. Not for use as dis. tmt.
C/I:Hypersens. Encephalopathy of unknown origin within 7 days of prev. immuniz. with a pertussis-cont. vacc. To be postponed in persons suffering from an ac. sev. febrile illness. Minor infect. is not a contraind.

Tetanus Vaccines. Diphtheria Toxoid 2 IU / 0.5 ml, Filamentous Haemagglutinin 8 mcg / 0.5 ml, Pertactin 2.5 mcg / 0.5 ml, Pertussis Toxoid 8 mcg / 0.5 ml, Tetanus Toxoid 20 IU / 0.5 ml.
PREFILLED SYRINGE/ SINGLE DOSE VIAL:
1. Deep I.M inject. See lit.
Booster vaccine against diphther.,
tetanus, pertussis from 10 yrs. of age.
C/I: Severe febrile illness, acute infect.,
hypersens.

Bacterial and Viral Vaccines. Diphtheria Toxoid 2 IU / 0.5 ml, Filamentous Haemagglutinin 8 mcg / 0.5 ml, Inactivated Poliovirus type 1 40 DU / 0.5 ml, Inactivated Poliovirus type 2 8 DU / 0.5 ml, Inactivated Poliovirus type 3 32 DU / 0.5 ml, Pertactin 2.5 mcg / 0.5 ml, Pertussis Toxoid 8 mcg / 0.5 ml, Tetanus Toxoid 20 IU / 0.5 ml.
PREFILLED SYRINGE (with stopper, with/
out needle): 1, 10 x 0.5 ml. Single dose,
deep I.M. in deltoid from 4 yrs old.
Repeat vaccinat. against diphth.,
tetanus, polio accord. official
recommends. See lit.
Booster vaccinat. against diphth.,
tetanus, pertussis, polio from 4 yrs old.
Not for primary immunisat.
C/I: Hypersens., also to neomycin,
polymycin, polysorbate 80,
formaldehyde. See lit.

Diphtheria Toxoid ≥2 IU, Tetanus Toxoid ≥20 IU, Aluminium Hydroxide 0.6 mg.
PREFILLED SYRINGES: 1, 10 x 0.5 ml.
Routine booster inj: Recomm. a single
dose of 0.5 ml I.M. every 10 years.
Primary vaccinat: 3 successive doses at
monthly intervals. Post-tetanus expos:
See vacc. schedule.
Adults over 18 years for routine booster
vaccinat. against diphtheria, tetanus.
Primary vaccinat. against diphtheria,
tetanus. Post-exposure follow. tetanusprone
wound, if booster inject. reqd.
C/I: Hypersens.

Bacterial and Viral Vaccines. Diphtheria Toxoid NLT 30 IU, Filamentous Haemagglutinin 25 mcg / 0.5 ml, Pertactin 8 mcg / 0.5 ml, Pertussis Toxoid 25 mcg / 0.5 ml, Tetanus Toxoid NLT 40 IU.
PREFILLED SYRINGES: 1 x 0.5 ml. 0.5 ml
in 3 doses with booster by deep I.M.
during 2nd and 6th yr. of life.
Active prim. immun. against diphth.,
tetanus and pertussis for age 2 mths. Booster (for child. prev. immun., with 3/4 doses of DTPa or DTPw).
C/I: Febrile illness, hypersens. to vaccine,
acute infect, past neurolog. complicats.

Bacterial and Viral Vaccines. Diphtheria Toxoid NLT 30 IU/dose, Filamentous Haemagglutinin 25 mcg/dose, Haemophilus Influenzae type b 10 mcg/dose, Hepatitis B Vaccine 10 mcg/dose, Pertactin 8 mcg/dose, Pertussis Toxoid 25 mcg/dose, Inactivated Poliovirus type 1 40 DU/dose, Inactivated Poliovirus type 2 8 DU/dose, Inactivated Poliovirus type 3 32 DU/dose, Tetanus Toxoid NLT 40 IU/dose.
RECONSTITUTED VACCINE: 1. 3 doses in
first 6 mths of life start. at 2 mths.
Booster dose: 2nd year of life. by deep
I.M. inject. at alt. sites for ea. inject. See
lit.
Active immunizant. from 2 mths. - 7 yrs.
against diphth., tetanus, pertussis (DTP)
and Hib.
C/I: Febrile illness, hypersens. to vaccine,
acute infect, past neurolog. complicats.
See lit.